"From biologic mechanisms to theragnostic paths in the Hereditary Cancer Syndromes: germline mutations as a therapeutic target" is the title of the meeting held at the Temple University, Friday, May 12. Although hereditary cancer…
The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is among the contributors for the drafting of the BECA Report by the Special Committee on Cancer of the European Parliament
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.